Latest AI and machine learning research in cardiovascular for healthcare professionals.
BACKGROUND: Early detection and treatment stratification of breast cancer remain major clinical chal...
RATIONALE AND OBJECTIVES: The 70-gene signature (MammaPrint) guides risk assessment and treatment in...
BACKGROUND: Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are aggressive sarcomas often arising ...
PURPOSE: To compare the efficacy and safety of optical navigation robot-assisted versus conventional...
BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive molecular subtype. With the new de...
Breast cancer remains a significant health concern for women worldwide. Ultrasound imaging is widely...
This phantom study aimed to determine whether a novel non-artificial intelligence image-sharpening a...
BACKGROUND: First-line treatment of gastric cancer is evolving with the integration of immune checkp...
Anthracycline chemotherapeutics are common chemotherapeutics that have substantial toxicities. There...
BACKGROUND: To develop a combined model integrating intratumoral and peritumoral delta-radiomics fro...
Human epidermal growth factor receptor 2 (HER2)-targeted therapies have revolutionized breast cancer...
BACKGROUND: Accurate prediction of breast cancer biomarkers - including oestrogen receptor (ER), pro...
BACKGROUNDS: Breast cancer (BRCA) represents the most prevalent malignancy globally, with projection...
BACKGROUND: Colorectal cancer (CRC) is a prevalent malignant tumor with increasing incidence and mor...
BACKGROUND: Doxorubicin (DOX)-based chemotherapy has improved survival outcomes in breast cancer pat...
RATIONALE AND OBJECTIVES: Transarterial radioembolization (TARE) is increasingly used for patients w...
BACKGROUND: The optimal treatment strategy for older patients with low-risk stage II or T3N0M0 nasop...
OBJECTIVE: To assess the value of multiparametric MRI (mpMRI)-derived radiomic signatures and a comb...
BACKGROUND: The successful design and implementation of artificial intelligence (AI)-driven solution...
Chemoresistance to 5-fluorouracil (5-FU) remains a critical barrier in colorectal cancer (CRC) manag...
BACKGROUND: The ability to predict pathological complete response (pCR) prior to neoadjuvant therapy...